Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Dr. Richard Marlink, Known Globally for Work Fighting AIDS, to Lead Rutgers’ Global Health Institute

5/6/2016

1 Comment

 
New Brunswick ― Richard G. Marlink, M.D., a Harvard professor recognized internationally for research and leadership in the fight against AIDS, will join Rutgers as the inaugural Henry Rutgers Professor of Global Health and director of a new Global Health Institute at Rutgers Biomedical and Health Sciences (RBHS).
 
At the start of the AIDS epidemic, Marlink was instrumental in setting up the first HIV/AIDS clinic in Boston and studied the impact of the HIV virus in west and central Africa.  
 
After helping to start the Botswana-Harvard Partnership in 1996, he founded the Kitso AIDS Training Program, which would become Botswana’s national AIDS training program. Kitso means knowledge in the local Setswana language.
 
Marlink, the Bruce A. Beal, Robert L. Beal, and Alexander S. Beal Professor of the Practice of Public Health at Harvard’s T.H. Chan School of Public Health and executive director of the Harvard AIDS Initiative, will join Rutgers in July, filling a key role in the strategic growth of RBHS: broadening the university’s presence in public health community efforts to improve health and wellness.
​“Richard Marlink’s goal is to drive Rutgers’ continued evolution as one of the leading global health centers in the country, linking together and building upon significant resources we are committing to improving the public health as part of our strategic plan,” said Brian Strom, RBHS chancellor.
 
Strom added, “His expertise as a researcher, scholar and leader of grassroots health care delivery will be vital to Rutgers as we undertake global health initiatives that assist populations locally and around the world.  His experiences will be particularly valuable in demonstrating to students how, as involved citizens, they can positively impact major societal issues.”
 
Initially, Marlink will focus on several areas: old and new infectious disease epidemics; the expanding burden of noncommunicable diseases in poor populations; the social and environmental threats to health, poverty and humanitarian crises; and inadequate local and developing country health systems.
 
Marlink will head the creation of a Global Health Institute that will support the development of global health research programs universitywide, the recruitment of faculty with interests in global health, and the creation of a web-based global health resource center for faculty and students with interests in these areas.
 
Marlink was the principal investigator for the Tshepo Study, the first large-scale antiretroviral treatment study in Botswana, in addition to conducting other clinical and epidemiological studies in the region.
 
Also in Botswana, he was the country director for Harvard’s contribution to the joint Botswana and United States governments’ HIV/AIDS and TB training, monitoring and evaluation PEPFAR effort.
 
In the mid-1980s in Senegal, Marlink was part of the team of Senegalese, French and American researchers who discovered and then studied the second type of human AIDS virus, HIV-2. Since then, he has been involved in multiple HIV/AIDS care, treatment and prevention programs in many African countries, including in Botswana, Côte d'Ivoire, Democratic Republic of the Congo, Kenya, Lesotho, Malawi, Mozambique, Rwanda, Senegal, South Africa, Swaziland, Tanzania, Uganda, Zambia and Zimbabwe. He has also organized initiatives to enhance HIV/AIDS care in Brazil, Puerto Rico and Thailand.
 
Marlink has served as the scientific director, the vice president for implementation and the senior adviser for medical and scientific affairs at the Elizabeth Glaser Pediatric AIDS Foundation, where he was principal investigator of Project HEART, a five-country CDC/PEPFAR effort in Africa.  
 
That project began in 2004 and by 2011 had placed more than 1 million people living with HIV into care clinics. More than 565,000 were placed on life-saving antiretroviral treatment.
 
Since 2000, Marlink has been the founding member of the board of directors of the African Comprehensive HIV/AIDS Partnerships, a public-partnership among the government of Botswana and the Bill and Melinda Gates and Merck Foundations to provide ongoing support for numerous HIV/AIDS prevention, care and treatment efforts in that country.
 
Marlink has authored or co-authored more than 125 scientific articles; written a textbook, Global AIDS Crisis: A Reference Handbook; and co-edited the book, AIDS in Africa, 2nd Edition.
 
Additionally, he served as chief editor for two special supplements to the journal AIDS and as executive editor of the seminal 320-author, three-volume textbook, From the Ground Up: A Guide to Building Comprehensive HIV/AIDS Care Programs in Resource Limited Settings.
 
A trained fellow in hematology/oncology at the Beth Israel Deaconess Medical Center at Harvard Medical School, Marlink received his medical degree from the University of New Mexico and his bachelor’s degree from Brown University.  
1 Comment
E Rang
3/21/2018 06:34:53 am

Suggestions for collaborative research and collaboration Preclinical, clinical collaboration and research for commercial approval of each country



Cell Immune Therapy -- An Innovative Vaccine Adjuvant Platform Study Material of Natural Killer-- Cell Therapy Mechanism



We all know the cause, progress, and outcome of cirrhosis.

You can check out a lot of materials and foods that are good for cirrhosis in classics and on the internet.

Hepatitis Cure is the only way that you can regenerate from hepatitis and cirrhosis.



However, it is a reality that we can not find cured data of liver pain which started from hepatitis (B, C-type).

Hepatitis is a chronic cirrhosis of the blood and organ damage caused by viral replication and proliferation for a long time.

This process also involves the same damage to the human body caused by HIV-aids viral replication.

It also includes viruses of mutations and variants that have emerged from the battle in the human body with hepatitis virus and antiviral agents of the aids virus.



Liver tissue cells are the original intact liver tissue cells without transformation of cells as they are born,

How much of the cell dysfunction caused by inflammation after infection with the virus allows infiltration?



If 20% of the liver tissue cells are normal, is not it hurting to live?

If so, 20% normal liver tissue cells will be able to enjoy water.

If we can completely kill the virus that causes inflammation in our body.



Look at the progression of cirrhosis in hepatitis (B, C-type aids).

Once the human infection of the blood-borne virus begins, the invading virus first attacks the human immune system.

It is not known exactly how much human evolution is, but in the battle against the blood-infecting virus that is attacked for the first time, the immune cell death of the white-backed louse begins to occur.



Blood production also works every moment, but immune cell death also works every moment, so the immune cell death rate is much faster than the blood production rate, which can confirm the rapid decline of immune cells.



In particular, the rate of progression of the immune cell decline in aids (2-type) can be determined by the replication and proliferation of viruses and the CD-4/8 (human immune cell) decline.

AIDS 2 type is a typical mutation and variant virus.



The recovery of normal levels of platelet counts, a barometer of decreased CD-4/8 levels and cirrhosis,

You can create a mechanism of healing of the complete killing of blood-borne viruses.



Human body structure helps the immune system to regenerate the normal immune system, which is only ingested by itself.

Natural foods that are naturally derived from natural foods can be checked by blood tests at 1 month after ingestion of platelets.

CD-4/8 numerical enhancement can be confirmed from about 3 months.



This is the reason why the virus (HIV, HBV, HCV, HIV + HCV, HIV + HBV, HBV + HCV) virus

It is a complete healing mechanism.

The late HBV = hepatitis B virus (3-type antigens) of the viral death of multiple infections is inevitable.



Chemical combinations can not produce human immunity.



The food intake formula is 3 meals a day, which is comfortable for us. * 5 =

Immune cell enhancement that can be cured after infection is possible.



So how do you compress the food you eat?

Is the flood-like material a vital source of information on the human body and its data?



The content of the various sites should not make it difficult for us to have the truly necessary difficulty of relieving the suffering of the pain that it is there to quote, follow, and come into contact with.

The hometown of natural food healing substances is found in a great number of natural forms in countries such as South, North Korea, China, India, the United States, and Canada.



It is a common food stipulated in an intentionally written book such as Dongbibo, Old Emperor,

Chinese herbal medicine, from 2 thousand BC,

They have not yet made a viral remedy for blood-borne infections.



I made it first in Korea.

The patent application is not yet.

At the crucial time, a batch of national and international patents are filed.



The production of antibody adjuvants and the use of antibodies is a natural progression.



We can develop vaccines and produce leukocytes when infected with HIV.



We propose cooperation and collaboration of following contents.

1 - Human Blood Infection Commercial approval of health functional foods for the treatment of viral diseases

Preclinical and Clinical Joint Research

Anti-HBc Pos 11.64

Anti - HBs Pos 11.8
2 - Manufacture of therapeutic vaccine using recovered blood antibody cells and liver tissue cells after infection with virus.

“This is an important advance in the field of antibody-based HIV vaccine development.”



3 - Proposal of HIV prevention and therapeutic vacc

Reply



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Health Care
    Healthcare
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608
732-729-9619